AEF0217 300 µg clinical trials

AEF0217 in Participants With Down Syndrome

This study looks at a new drug, AEF0217, for people with Down Syndrome, aged 16-32. It aims to see if the drug helps with daily activities and is safe. Participants will take the drug or a dummy pill for 24 weeks.